These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 8268852)
1. Cytochrome P450 isozymes catalyzing the hepatic microsomal oxidation of 9-anthraldehyde to 9-anthracene carboxylic acid in adult male rats. Matsunaga T; Iwawaki Y; Watanabe K; Narimatsu S; Yamamoto I; Imaoka S; Funae Y; Yoshimura H Biol Pharm Bull; 1993 Sep; 16(9):866-9. PubMed ID: 8268852 [TBL] [Abstract][Full Text] [Related]
2. Microsomal aldehyde oxygenase (MALDO): purification and characterization of a cytochrome P450 isozyme responsible for oxidation of 9-anthraldehyde to 9-anthracenecarboxylic acid in monkey liver. Matsunaga T; Iwawaki Y; Watanabe K; Yamamoto I; Kageyama T; Yoshimura H J Biochem; 1996 Apr; 119(4):617-25. PubMed ID: 8743560 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis. Chen J; Murray M; Liddle C; Jiang XM; Farrell GC Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428 [TBL] [Abstract][Full Text] [Related]
4. Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1). Halvorson M; Greenway D; Eberhart D; Fitzgerald K; Parkinson A Arch Biochem Biophys; 1990 Feb; 277(1):166-80. PubMed ID: 2106291 [TBL] [Abstract][Full Text] [Related]
5. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion. Butler AM; Murray M Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222 [TBL] [Abstract][Full Text] [Related]
6. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Nadin L; Butler AM; Farrell GC; Murray M Gastroenterology; 1995 Jul; 109(1):198-205. PubMed ID: 7797018 [TBL] [Abstract][Full Text] [Related]
7. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. Chen J; Farrell GC J Gastroenterol Hepatol; 1996 Sep; 11(9):870-7. PubMed ID: 8889968 [TBL] [Abstract][Full Text] [Related]
8. Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid. Watanabe K; Matsunaga T; Narimatsu S; Yamamoto I; Imaoka S; Funae Y; Yoshimura H Biochem Pharmacol; 1991 Aug; 42(6):1255-9. PubMed ID: 1653566 [TBL] [Abstract][Full Text] [Related]
9. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase. Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203 [TBL] [Abstract][Full Text] [Related]
10. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline. Murray M Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757 [TBL] [Abstract][Full Text] [Related]
11. 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human. Marini S; Grasso E; Longo V; Puccini P; Riccardi B; Gervasi PG Xenobiotica; 2003 Jan; 33(1):1-11. PubMed ID: 12519690 [TBL] [Abstract][Full Text] [Related]
12. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
13. Nicotine metabolism by rat hepatic cytochrome P450s. Nakayama H; Okuda H; Nakashima T; Imaoka S; Funae Y Biochem Pharmacol; 1993 Jun; 45(12):2554-6. PubMed ID: 8328992 [TBL] [Abstract][Full Text] [Related]
14. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants. Murray M; Field SL Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495 [TBL] [Abstract][Full Text] [Related]
15. Expression of hepatic microsomal cytochrome P450s as altered by uremia. Ikemoto S; Imaoka S; Hayahara N; Maekawa M; Funae Y Biochem Pharmacol; 1992 Jun; 43(11):2407-12. PubMed ID: 1610404 [TBL] [Abstract][Full Text] [Related]
16. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides. Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480 [TBL] [Abstract][Full Text] [Related]
18. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636 [TBL] [Abstract][Full Text] [Related]
19. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes. Nomura A; Sakurai E; Hikichi N J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341 [TBL] [Abstract][Full Text] [Related]
20. Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol. Kraner JC; Morgan ET; Halpert JR J Pharmacol Exp Ther; 1994 Sep; 270(3):1367-72. PubMed ID: 7932191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]